Saturday, October 17, 2026 | 01:16 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Laurus Labs Ltd Quarterly Results

Q1 FY26-27 Results Summary

Revenue

The revenue stands at ₹2,026.31 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.85 per cent from ₹1,811.57 crore. This corresponds to a year-on-year *(YoY) growth of 29.10 per cent.

Operating Profit

Operating Profit stands at ₹638.27 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.64 per cent from ₹512.11 crore. This corresponds to a year-on-year *(YoY) growth of 67.03 per cent.

PBDT

PBDT stands at ₹605.31 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.15 per cent from ₹483.65 crore. This corresponds to a year-on-year *(YoY) growth of 77.17 per cent.

Profit Before Tax

Profit Before Tax stands at ₹481.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 33.16 per cent from ₹361.55 crore. This corresponds to a year-on-year *(YoY) growth of 114.14 per cent.

Net Profit

Net Profit stands at ₹362.07 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.35 per cent from ₹282.09 crore. This represents a 123.94 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Laurus Labs Ltd Earnings

Data not available

Laurus Labs Ltd Earning Charts

Revenue from Operations

in ₹ cr

EBITDA

in ₹ cr

Profit before Tax

in ₹ cr

Net Profit

in ₹ cr

Laurus Labs Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 1,280Motilal Oswal26-Feb-2026
Buy 1,110Motilal Oswal24-Oct-2025

Laurus Labs Ltd Financial Reports

Filter By:
Loading...

Laurus Labs Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 month3 month6 month1 Year
Laurus Labs1.93%-0.58%5.31%32.05%82.27%123.63%
Divi's Lab.1.99%-1.70%-1.57%25.92%46.78%39.63%
Torrent Pharma.-0.78%-2.54%-5.08%-8.86%8.88%27.72%
Zydus Lifesci.-1.44%-1.29%-2.49%-1.95%20.07%12.19%
Cipla-0.65%0.86%-3.39%-8.08%7.82%-19.17%
Dr Reddy's Labs0.91%0.11%5.19%0.70%-0.03%-3.94%
Aurobindo Pharma-0.90%-2.51%-4.32%6.37%21.37%50.90%

Company Info

Company Information

Executive Director & CEO : CHAVA SATYANARAYANA

Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM

Executive Director : Chandrakanth Chereddi

Director : Narendra Ostawal

Independent Director : Aruna Bhinge

Independent Director : Rajesh Koshy Chandy

Independent Director : Ramesh Subrahmanian

Company Secretary : G Venkateswar Reddy

Chairman : M Venu Gopala Rao

Independent Director : Ravindranath Kancherla

Executive Director : Venkata Lakshmana Rao Chunduru

Laurus Labs Ltd News

Data Not Available